Accurate and reliable detection of Flu A, Flu B or RSV in as soon as 20 minutes*
To accurately diagnose pharyngitis caused by Group A Streptococcus (GAS) due to increasing incidence and prevalence globally.
- Annually, 616 million people have GAS pharyngitis, more than 18.1 million people develop severe GAS disease and more than 517,000 people die due to severe GAS disease.1
Reduce overuse of antibiotics for the treatment of pharyngitis.
- Based on recent literature, 37% of children presenting with pharyngitis tested positive for GAS, however 56% of visits were associated with antibiotic prescriptions. Similarly, 18% of adults presenting with pharyngitis caused by GAS, but 72% were treated with antibiotics.2
(1) The Global Burden of Group A Streptococcal Diseases. Lancet Infect Dis. 2005 Nov; 5(11):685-94.
(2) Fleming-Dutra KE, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016 May 3;315(17):1864-73.
- Cepheid provides on-demand testing for Group A Strep in as soon as 18 minutes.*
- Careful selection of the target gene produces quality results.
- Delivering accurate and timely results optimizes fast treatment decisions and eliminates the need to perform culture confirmation of negative results.
* With Early Assay Termination for positive results.
Refer to Package Insert Xpert Xpress Strep A 301-6574 Rev B and 301-8667 Rev A.
- Accurate diagnosis of GAS supports antimicrobial stewardship and may reduce the amount of patients inappropriately prescribed antibiotics.
- Gain testing efficiencies and reduce costs by eliminating culture confirmation testing.3
- Reduce the risk of GAS complications such as rheumatic fever and glomerulonephritis.
- Improve patient satisfaction with quicker time to result and appropriate prescriptions.
(3) Workflow studies conducted by Cepheid Solutions demonstrate that a throat culture confirmation workup costs~ $9.13 per culture. (Average cost includes reagents, labor cost and time). Data on file.
Xpert® Xpress Strep A
Number of Tests: 10Catalog #: XPRSTREPA-10
Xpert® Xpress Strep A
Number of Tests: 120Catalog #: XPRSTREPA-120
Acute Pharyngitis Visits in the ED: What’s the Big Deal?
Acute pharyngitis is a frequent complaint seen in the Emergency Department, and group A Streptococcus is the most common bacterial etiology of pediatric pharyngitis. Globally, 616 million people are diagnosed annually with group A Streptococcus (GAS) pharyngitis. Of these, 18.1 million cases develop severe GAS disease, and 517,000 people die every year due to GAS disease. Understand why the status quo of testing has led to missing GAS cases and overuse of antibiotics for treatment. Learn how new advances in rapid molecular testing can improve your test results and aid in effective management of your patients.
Antibiotic Stewardship in the Emergency Department
This webinar discusses the importance of diligent antimicrobial stewardship and accuracy of diagnostic tests for the detection of Group A Streptococcus pharyngitis. It provides commentary on the high confidence that molecular testing affords the antibiotic steward and how technology can reduce the practice of prescribing antibiotics "just-in-case" there is an infection, especially as testing moves closer to the patient.